Vesicular monoamine transporter-2: Immunogold localization in striatal axons and terminals

被引:0
|
作者
Nirenberg, MJ
Chan, J
Liu, YJ
Edwards, RH
Pickel, VM
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143
关键词
ultrastructure; dopamine; caudate-putamen; synaptic vesicle; densecore vesicle;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The vesicular monoamine transporter-2 (VMAT2) mediates the reserpine-sensitive neuronal uptake of monoamines into vesicles and other intracellular organelles. Accordingly, this transporter is expressed at high levels in regions that contain a dense monoamine innervation, such as the rat dorsolateral striatum. We used ultrastructural immunocytochemistry in this region to show that immunogold labeling for VMAT2 is present in varicose axonal processes, many of which also contain the catecholamine-synthesizing enzyme tyrosine-hydroxylase. Within these mainly dopaminergic processes, VMAT2 was associated with small synaptic vesicles (SSVs) and more rarely with large dense-core vesicles or tubulovesicles. These findings suggest that SSVs are the major organelles involved in the storage and release of dopamine in the dorsolateral striatum. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:194 / 198
页数:5
相关论文
共 50 条
  • [21] Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: Potential sites for somatodendritic storage and release of dopamine
    Nirenberg, MJ
    Chan, J
    Liu, YJ
    Edwards, RH
    Pickel, VM
    JOURNAL OF NEUROSCIENCE, 1996, 16 (13): : 4135 - 4145
  • [22] HIV-1 Tat Protein Decreases Dopamine Transporter Cell Surface Expression and Vesicular Monoamine Transporter-2 Function in Rat Striatal Synaptosomes
    Narasimha M. Midde
    Adrian M. Gomez
    Jun Zhu
    Journal of Neuroimmune Pharmacology, 2012, 7 : 629 - 639
  • [23] Role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review
    Warlick, Halford
    Tocci, Darcy
    Prashar, Sukriti
    Boldt, Erick
    Khalil, Alena
    Arora, Simran
    Matthews, Thomas
    Wahid, Talha
    Fernandez, Richard
    Ram, Dhiya
    Leon, Lexie
    Arain, Arisha
    Rey, Jose
    Davis, Kelley
    PSYCHOPHARMACOLOGY, 2024, 241 (11) : 2191 - 2203
  • [24] Synthesis and evaluation of a series of tropane analogues as novel vesicular monoamine transporter-2 ligands
    Zheng, GR
    Dwoskin, LP
    Deaciuc, AG
    Crooks, PA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) : 4463 - 4466
  • [25] 9-Cyclopropylmethoxy-dihydrotetrabenazine and its stereoisomers as vesicular monoamine transporter-2 inhibitors
    Wang, Wenyan
    Lin, Shilan
    Du, Guangying
    Bai, Xinfa
    Lu, Jing
    Ye, Liang
    Wang, Hongbo
    Zhang, Rui
    Tian, Jingwei
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (13) : 991 - 1003
  • [26] Synthesis and evaluation of 2-amino-dihydroxytetrabenazine derivatives as probes for the vesicular monoamine transporter-2
    Zhu, Lin
    Liu, Jingying
    Kung, Hank F.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [27] Dopamine D2 receptor agonists increase vesicular monoamine transporter-2 function
    Truong, JG
    Rau, KS
    Hanson, GR
    Fleckenstein, AE
    FASEB JOURNAL, 2003, 17 (05): : A1025 - A1025
  • [28] Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals
    Lohr, Kelly M.
    Chen, Merry
    Hoffman, Carlie A.
    McDaniel, Miranda J.
    Stout, Kristen A.
    Dunn, Amy R.
    Wang, Minzheng
    Bernstein, Alison I.
    Miller, Gary W.
    TOXICOLOGICAL SCIENCES, 2016, 153 (01) : 79 - 88
  • [29] Histamine uptake by human endometrial cells expressing the organic cation transporter EMT and the vesicular monoamine transporter-2
    Noskova, Vera
    Bottalico, Barbara
    Olsson, Hanna
    Ehinger, Anna
    Pilka, Radovan
    Casslen, Bertil
    Hansson, Stefan R.
    MOLECULAR HUMAN REPRODUCTION, 2006, 12 (08) : 483 - 489
  • [30] Age-Dependent Differences in Dopamine Transporter and Vesicular Monoamine Transporter-2 Function and Their Implications for Methamphetamine Neurotoxicity
    Volz, Trent J.
    Farnsworth, Sarah J.
    Rowley, Shane D.
    Hanson, Glen R.
    Fleckenstein, Annette E.
    SYNAPSE, 2009, 63 (02) : 147 - 151